WALTHAM, Massachusetts, Dec. 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its January 2023 edition:

Original Articles:

* IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

* A Bayesian Interpretation of a Pediatric Cardiac Arrest Trial (THAPCA-OH)

* Colisti . . .

Click here for more information about our products